Physical activity in patients with COPD von Watz, H, Waschki, B, Meyer, T, Magnussen, H

Volltext

Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram‐negative bacteria von Keyser, P., Elofsson, M., Rosell, S., Wolf‐Watz, H.

Volltext

SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects von Holz, O, Khalilieh, S, Ludwig-Sengpiel, A, Watz, H, Stryszak, P, Soni, P, Tsai, M, Sadeh, J, Magnussen, H

Volltext

Small-Molecule Inhibitors Specifically Targeting Type III Secretion von Nordfelth, R, Kauppi, A. M, Norberg, H. A, Wolf-Watz, H, Elofsson, M

Volltext

The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET von Kahnert, K., Foehrenbach, M., Lucke, T., Alter, P., Trudzinski, F. T., Bals, R., Lutter, J. I., Timmermann, H., Soehler, S., Foerderreuther, S., Nowak, D., Watz, H., Waschki, B., Behr, J., Welte, T., Vogelmeier, C. F., Joerres, R. A.

Volltext

Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD von Cahn, A., Hamblin, J.N., Begg, M., Wilson, R., Dunsire, L., Sriskantharajah, S., Montembault, M., Leemereise, C.N., Galinanes-Garcia, L., Watz, H., Kirsten, A.M., Fuhr, R., Hessel, E.M.

Volltext

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort von Alter, Peter, Mayerhofer, Barbara A, Kahnert, Kathrin, Watz, Henrik, Waschki, Benjamin, Andreas, Stefan, Biertz, Frank, Bals, Robert, Vogelmeier, Claus F, Jörres, Rudolf A

Volltext

Association of Airway Eosinophilia with Small Airway Dysfunction in Patients with Mild and at Risk for COPD von Abdo, Mustafa, Pedersen, Frauke, Trinkmann, Frederik, Herth, Felix J.F, Rabe, Klaus F, Kirsten, Anne-Marie, Watz, Henrik

Volltext

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD von Watz, Henrik, Troosters, Thierry, Beeh, Kai M, Garcia-Aymerich, Judith, Paggiaro, Pierluigi, Molins, Eduard, Notari, Massimo, Zapata, Antonio, Jarreta, Diana, Garcia Gil, Esther

Volltext

Specificity of cognitive biases in patients with current depression and remitted depression and in patients with asthma von Fritzsche, A., Dahme, B., Gotlib, I. H., Joormann, J., Magnussen, H., Watz, H., Nutzinger, D. O., von Leupoldt, A.

Volltext

Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study von Koopman, Maud, Franssen, Frits M E, Gaffron, Swetlana, Watz, Henrik, Troosters, Thierry, Garcia-Aymerich, Judith, Paggiaro, Pierluigi, Molins, Eduard, Moya, Miguel, van Burk, Lindy, Maier, Dieter, Garcia Gil, Esther, Wouters, Emiel F M, Vanfleteren, Lowie E G W, Spruit, Martijn A

Volltext

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET von Alter, Peter, Kahnert, Kathrin, Trudzinski, Franziska C, Bals, Robert, Watz, Henrik, Speicher, Tim, Sohler, Sandra, Andreas, Stefan, Welte, Tobias, Rabe, Klaus F, Wouters, Emiel F.M, Sassmann-Schweda, Antonia, Wirtz, Hubert, Ficker, Joachim H, Vogelmeier, Claus F, Jorres, Rudolf A

Volltext

The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD von Kirsten, A.M, Förster, K, Radeczky, E, Linnhoff, A, Balint, B, Watz, H, Wray, H, Salkeld, L, Cullberg, M, Larsson, B

Volltext

Rating sputum cell quality in clinical trials for asthma and COPD treatment von Pedersen, Frauke, Zissler, Ulrich M, Watz, Henrik, Rabe, Klaus F, Hohlfeld, Jens M, Holz, Olaf

Volltext

Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis von Watz, Henrik, Rickard, Kathleen, Rheault, Tara, Bengtsson, Thomas, Singh, Dave

Volltext

Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus von Ramakrishnan, Sanjay, Janssens, Wim, Burgel, Pierre-Regis, Contoli, Marco, Franssen, Frits M. E., Greening, Neil J., Greulich, Timm, Gyselinck, Iwein, Halner, Andreas, Huerta, Arturo, Morgan, Rebecca L., Quint, Jennifer K., Vanfleteren, Lowie E. G. W., Vermeersch, Kristina, Watz, Henrik, Bafadhel, Mona

Volltext

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptom... von Sethi, Sanjay, Kerwin, Edward, Watz, Henrik, Ferguson, Gary T, Mroz, Robert M, Segarra, Rosa, Molins, Eduard, Jarreta, Diana, Garcia Gil, Esther

Volltext

TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow von Mahler, Donald A., Ludwig-Sengpiel, Andrea, Ferguson, Gary, de la Hoz, Alberto, Ritz, John, Shaikh, Asif, Watz, Henrik

Volltext

Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort von Lutter, Johanna, Joerres, Rudolf A., Welte, Tobias, Watz, Henrik, Waschki, Benjamin, Alter, Peter, Trudzinski, Franziska C., Ohlander, Johan, Behr, Juergen, Bals, Robert, Studnicka, Michael, Holle, Rolf, Vogelmeier, Claus F., Kahnert, Kathrin

Volltext

Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET von Kahnert, Kathrin, Joerres, Rudolf A., Lucke, Tanja, Trudzinski, Franziska C., Mertsch, Pontus, Bickert, Christiane, Ficker, Joachim H., Behr, Juergen, Bals, Robert, Watz, Henrik, Welte, Tobias, Vogelmeier, Claus F., Alter, Peter

Volltext